Contemporary management of patients referring to cardiologists one to three years from a myocardial infarction: The EYESHOT Post-MI study. (15th December 2018)

• Record Type: Journal Article
• Authors: De Luca, Leonardo; Piscione, Federico; Colivicchi, Furio; Lucci, Donata; Mascia, Franco; Marinoni, Barbara; Cirillo, Plinio; Grosseto, Daniele; Mauro, Ciro; Calabrò, Paolo; Nardi, Federico; Rossini, Roberta; Geraci, Giovanna; Gabrielli, Domenico; Di Lenarda, Andrea; Gulizia, Michele Massimo
• Is Part Of: International journal of cardiology. Volume 273(2018)
• Page Start: 8
• Page End: 14
• Publication Date: 2018-12-15
• Subjects: Post-MI -- Secondary prevention -- Percutaneous coronary intervention -- Dual antiplatelet therapy -- Ticagrelor -- Clopidogrel; Cardiology -- Periodicals; Electronic journals; 616.12
• DOI: 10.1016/j.ijcard.2018.08.055
• Languages: English
• ISSNs: 0167-5273

Abstract

Abstract: Aims: To describe the contemporary management by cardiologists of patients after an episode of myocardial infarction (MI). Methods: The EYESHOT Post-MI was a prospective, observational, nationwide study aimed to evaluate the management of patients referring to cardiologists 1 to 3 years from the last MI event. Results: Over a 3-month period, 1633 consecutive patients [median 22 (IQR 15–28) months from MI] were enrolled: 1028 (63.0%) at the second and 605 (37.0%) at the third year from MI. During the 12 months prior to enrolment, the majority of patients received a transthoracic echocardiogram (60% and 54%), followed by coronary angiography (24% and 16%, in the second and third year from MI groups, respectively). At the time of enrolment, the majority of patients were prescribed on statins (93%) and beta-blockers (82%), without significant differences between the 2 groups. A dual antiplatelet therapy (DAPT) was used more frequently among patients presenting during the second compared to the third year from MI (40% vs 24%; p < 0.0001). At multivariable analysis, the time interval from last MI (2 vs 3 years: OR 2.27; 95% CI 1.79–2.88; p < 0.0001) and a previous percutaneous coronary intervention with multiple stents (OR 3.46; 95% CI 2.19–5.47; p < 0.0001) resulted as the major independent predictors of DAPT persistence at the time of enrolment. Conclusions: This contemporary registry provides unique insights into the current management of post-MI patients and represents an opportunity to further improve the long-term treatment of this high-risk population. Highlights: The EYESHOT Post-MI evaluated the management of patients referring to cardiologists 1 to 3 years from the last MI event. Over a 3-month period, 1633 patients were enrolled: 1028 (63.0%) at the second and 605 (37.0%) at the third year from MI. During the 12 months prior to enrolment, the majority of patients received a transthoracic echocardiogram, followed by coronary angiography. A dual antiplatelet therapy (DAPT) was used more frequently among patients presenting during the second compared to the third year from MI.